Company Overview

Memorial University of Newfoundland As part of its charter, Memorial has specific objectives: to develop an institute of higher learning deserving of respect for the quality of its academic standards and its research; to make the university accessible to all Newfoundlanders; and to establish new programs to meet the expanding needs of the province.

Seabright Corporation Limited Established by Memorial in 1987 Seabright Corporation Ltd. Is a not-for-profit organization which identifies and commercializes promising technologies arising from research at the University. In addition to its central role of transferring technology to the private sector, Seabright assists the province's small and medium size businesses to access the vast physical and human resources of the University. Seabright is privately owned by Memorial and governed by a board of directors representing industry, academia, and government. Seabright focuses on new technologies, processes, and services an products which enhance, improve and / or diversify an existing industry's capability, or create a new industry which does not compete with the existing private sector.

Seabright's Goals 1- Review research activities at Memorial to identify and commercialize those new applications of research with potential for significant economic benefit to the University of Newfoundland and Labrador. Examples could include royalty revenue generation, significant market penetration, "core ro platform"technologies which can be transferred to existing Newfoundland enterprises pursuing national or international markets and / or which can be used as the vehicle for the creation of such enterprises.

2- Promote and facilitate collaborative R&D

3- Promote and facilitate private sector access to university resources.

Environmental Profile

GENESIS Group Inc. is privately owned by Memorial University of Newfoundland and is governed by a board of directors representing industry, academia, and government. As a not-for-profit organization, GENESIS focuses on the development of new technologies, processes, services and products which enhance, improve and/or diversify an existing industry's capability, or create a new industry which does not compete with the existing private sector.

Company Information

Additional Details

Legal Name: Genesis Group Inc.

Number of Employees: 4

Contacts

Services

• Biotechnology
• Dna Analysis

  Bio-ID Corporation Limited was formed in 1990 to develop and promote a novel procedure referred to as Forensically Informative Nucleotide Sequencing (FINS). This process can determine the biological origin of a specimen (i. e. the species or breed of animal from which the sample came). Unlike conventional methods of specie identification, which usually depend on morphological characteristics of biochemical genetics which usually depend on morphological characteristics of biochemical genetics which examine proteins, FINS makes use of DNA - the molecule that contains the genetic information. A species' DNA consists of segments that are (1) unique to individuals, (2) shared by breeds or populations, (3) found in all members of that species, and (4) common in related species. FINS combines procedures in biotechnology with a data base that is under constant construction.

Products

• Antifreeze Proteins
• Aqualert Whale Alarm

  The AQUALERT emits an acoustic warning signal which can be detected by whales, porpoises and dolphins at ranges exceeding 1 km, alerting them to the presence of the fishing gear and allowing them to avoid becoming entrapped. Field tests of the AQUALERT have been conducted off the coast of New Hampshire, USA, on groundfish gillnets, off the coast of Newfoundland, Canada on cod traps, and in waters off Queensland, Australia on shark gillnets. The results showed significant reductions in the by-catch of humpback whales.

  The Government of Queensland was very impressed with the AQUALERT during the test program and has purchased 75 units for the continued prevention of whale entrapment. Preliminary testing of these units on groundfish gillnets has indicated promising results in reduction of harbour porpoise by-catch.

  The AQUALERT attaches easily to fishing gear and emits a consistent, loud acoustic warning signal which emanates in all directions at an interval which can be set to 3, 6, or 10 seconds. The signal is well within the audible frequency range of marine mammals and can be detected at ranges of 1 km or more. Range will vary depending on species and ambient noise levels.

  Features include: Dimensions are: 30 cm height, 17 cm maximum diameter Durable design constructed of aluminum alloy with zinc anodes to prevent corrosion, no protruding parts to tangle with gear Functions continuously for up to 12 weeks on one battery Reusable, will provide many seasons of protection. Powered by common 6 V alkaline lantern battery which is easily replaced Weighs 3.5 kg, is neutrally buoyant AQUALERT price is $400 U. S. Special pricing is available to those groups or organizations willing to provide documentation of by-catch data for fishing equipment protected by AQUALERT.

• Biological Control Agent

  Researchers at Memorial University of Newfoundland, have conducted research on a biological control agent specifically for spruce budworm and hemlock looper and have identified a naturally-occurring fungus that uses these pests' larval stage as its host. The researches have developed a growing median for the biological reactor to produce the fungus, while having it remain virulent to spruce budworm and hemlock looper. The concept of the use of this fungus is to dope the forest with hyphal bodies to the fungus early in the insect infestation and enhance the natural process, thereby strictly limiting the magnitude of the infestation. This product would be a market for this technology include the provincial departments and organizations that are charged with the responsibility of forest pest control.

• Carotenoid Yeast

  A new strain of carotenoid yeast has been isolated from yoghourt which shows promise a sa source for pigment and protein feed for aquacultured species. The new yeast was able to utilize a wide variety of organic nitrogen sources such as molasses and grew in a wide pH range (pH3-10). When compared with Phaffia rhodozyma, the carotenoid yeast grew much faster attaining a much superior biomass yield. (g dry wt/L), and a greater concentration of pigment. The new carotenoid yeast could replace the use of astaxanthin which is used primarily as a color supplement in fish and poultry feeds to increase, the red colouration of fish flesh and yellow colouration of egg yolks.

• Cheese-ripening Enzyme

  A bacterial enzyme has been developed to provide a means of producing Cheddar cheese with a reduced ripening period. When the enzyme is added to raw, pasteurized or partially pasteurized milk used for cheese making it accelerate the cheese ripening process. The enzyme has no direct effect on the growth of starter cultures normally employed in cheese making and can be added to the milk either before or after the addition of such starter cultures and either before or simultaneously with the addition of the renetting agent. The manufacture of Cheddar cheese can then be carried out entirely in the conventional way to give a Cheddar cheese product which ripens more quickly than conventional Cheddar cheese, thereby reducing the considerable cost of providing storage for the ripening process. This ripening aid can be used in conjunction with calf rennet or any rennet substitute, although those of animal origin are preferred.

• Early Response Gene

  The present invention relates to a novel family of immediate early response genes discovered during embryonic development. This family of mammalian genes are transcribed in the immediate early phase following exposure to FGF during mesoderm induction, termed Mesoderm Induction Early Response (MIER) genes. One member of this mammalian family of genes, the Er1 gene, has been found over-expressed in breast carcinoma and cervical carcinoma cell lines. Er1 is also over expressed in an abnormal T-cell subset (CD28-) whose numbers increase with disease progression in AIDS patients. This CD28- subset also increases in chronic inflammatory disorders. Therefore this gene and its product are potential targets for diagnosis and treatment of various cancers as well as immune disorders such as AIDS. This family of genes could have many uses in Cancer and AIDS diagnostic and therapeutic applications such as: use in drug design, vaccination protocols, diagnostic markers for rapidly proliferating cells, diagnostic kits containing antibodies to the gene product of any one of the gene members, use as primers in PCR amplification for R&D purposes, screening assays, etc.

• Empreintes D'hydrocarbures Au Moyen Des Techniques De Pointe De Cg/ C/Smri.
• Environmental Products And Services
• Growth Medium For Forest Pest Control Agent.

  The Biology Dept. At Memorial University of Newfoundland has been conducting research in a control agent for spruce budworm/hemlock looper and has identified a naturally occurring fungus that uses these pests' larval stages as its hosts, and is probably a major factor in the natural collapse of the pest population. A growing medium Patent (pending) has been developed for use in a biological reactor to produce the fungus, while having it remain virulent to spruce budworm and hemlock looper!

  The concept of the use of this fungus is to dope the forest with hyphal bodies of the fungus early in the insect infestation, and enhance the natural process, thereby strictly limiting the magnitude of infestation. The fungus has been produced in 10 L scale fermenters, and has been tested and found effective in Forestry Canada's greenhouses. A U. S. patent has been issued and a Canadian patent is pending.

• Immunological Reagents

  Terra Nova Biotechnology Co. Ltd. (TNB) is a privately-held company based in St. John's, Newfoundland, Canada since 1988. TNB uses its expertise in immunology and molecular biology to develop, produce, and market monoclonal antibodies for in-vitro diagnostic use. TNB is producing a set of monoclonal antibodies, in kit form, against the polymorphism of HLA-DP that will allow tissue typing to be done by serological methods. This will play a crucial role in matching bone marrow transplant (BMT) donors/recipients. TNB's recent research into the Human Leucocyte Antigen, HLA-DR4, has resulted in production of monoclonal antibodies capable of recognizing the specific subsets of the HLA system that are associated with an individual's susceptibility to rheumatoid arthritis. Since May 1995, the company has been marketing the NovaPRO test kit which has potential to play a key role in both the diagnosis and prognosis of rheumatoid arthritis patients. In addition, the company undertakes genetic testing in cases of disputed paternity. TNB also offers specialized services related to production and research such as contract mAb manufacturing and investigative R&D for its customers. http: //www. ucs. mun. ca/~tnb

• Liposome Delivery System

  Researches have developed an economic and practical delivery system for biological materials for use in aquaculture. Entrapment of antigen into multi-lamellar vesicles (liposomes), has been demonstrated by MUN researches to enhance immune responses to the associated antigen. The use of liposomes to encapsulate antigens can also adjuvant activity and potentially increase immune responses to antigens delivered via any route. The liposomal delivery system technology can be designed to package and deliver vaccines, antibodies, vitamins and minerals, viruses and any other components requiring packaging. This technology could improve fish quality and quantity by reducing fish disease in fish husbandry.

• Nutritional Factors To Control Fish Reproduction

  Fish Feeding regimes and strategies for controlling the onset or delay of reproduction in aquaculture subjects, preferable by using cheap, naturally occurring or slightly modified food components is under investigation. Several hey biochemical factors have been identified as being the key to manipulating reproduction in fish. The manipulation of reproduction in other fish is being studied using the same biochemical factors. The critical periods for when to add these biochemical factors to the feed regimes is under investigation. The possibility that feeding can be manipulated to "turn-off" fish reproduction means that energy can be directed to muscle (flesh) quality rather than reproduction. The nutritional control of fish reproduction is reversible so that fish which shoe good growth characteristics after "turn-off" can be subsequently used as brood stock.

• Powdered Cooked Cures Meat Pigment

  PA Pure Additions Inc., through its extensive research, has developed a powdered cooked-cured-n\meat pigment which is identical to the natural pink-colored pigment found in nitrite cured-meat. This pigment, in combination with a sequestrant, an antioxidant and an antimicrobial agent for meat curing, has been found very effective in reproducing the color, oxidative stability and flavor, as well as the antimicrobial effects of nitrite. The pigment combination has been applied to both solid and emulsified meat products, tested and found effective. The sensory acceptability of this nitrite alternative has been tested through the use of blind taste-tests, with excellent results.

• Transport Protein

  The invention pertains to the use of a TRANSPORT PROTEIN used to transport and load molecules (diagnostic and pharmaceutical agents) into lipoprotein particles (LDL, VLDL, HDL) which subsequently have use as a delivery system. One advantage of this system is that a larger amount of an "agent" can be loaded into a lipoprotein particle without destabilizing the delivery system and allows the system to retain the natural biological appearance of the human LDL particle. Lipoprotein meets most of the requirements for a satisfactory drug carrier:

  -they are endogenous and can avoid such typical carrier problems as immunological reaction and rapid plasma clearance due to uptake by reticuloendothelial cells;

  -receptor-mediated endocytosis enables intracellular uptake of the drug in specific tissues;

  -lipoprotein particles are totally biodegradable;

  -they provide a biocompatible vehicle for lipophilic drugs. This is of special importance if the drug is prone to decomposition.

  The improved particles have application towards:

  1)development of novel anticancer therapy;

  2)development of diagnostic radiopharmaceuticals for early detection of atherosclerosis 3)development of diagnostic radiopharmaceuticals for detection of tumors;

  4)development of specific anti-HIV drug therapy;

  5)potential development of specific delivery vehicles for gene therapy 6)cosmetic applications.

NAICS Categories

• 611710 Educational Support Services

Additional Information